PAS
ATNM icon

Point72 Asia (Singapore)’s Actinium Pharmaceuticals ATNM Stock Holding History

Point72 Asia (Singapore)’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$16.5K Sell
10,295
-10,747
-51% -$17.5K ﹤0.01% 736
2025
Q2 		$29.5K Buy
+21,042
New +$31.5K 0.01% 685

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asia (Singapore)'s ATNM Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its Actinium Pharmaceuticals (ATNM) stake by 51% in Q3 2025, selling an estimated $17.5K and leaving 10,295 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #736.

Point72 Asia (Singapore) first reported a position in ATNM in Q2 2025 and has held it in 2 quarters since. The position peaked at $29.5K in Q2 2025. 61 funds tracked by Wall St. Rank hold ATNM as of Q3 2025.

  • Point72 Asia (Singapore) held 10,295 shares of Actinium Pharmaceuticals worth $16.5K as of Q3 2025.
  • Point72 Asia (Singapore) sold 10,747 Actinium Pharmaceuticals shares in Q3 2025, an estimated $17.5K.
  • Actinium Pharmaceuticals made up ﹤0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #736 holding.
  • Point72 Asia (Singapore) first reported a position in Actinium Pharmaceuticals in Q2 2025 and has held it in 2 quarters since.
  • Point72 Asia (Singapore)'s Actinium Pharmaceuticals position peaked at $29.5K in Q2 2025.
  • 61 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.